ABSTRACT
Modern biotechnology - the controversial manipulation of genes in living organisms - has far-reaching implications for agriculture, human health, trade and the environment. Against the odds, an international treaty governing biosafety and trade in biotechnology was adopted in 2000. The Cartagena Protocol on Biosafety of the Convention on Biological Diversity deals with one of the most important and challenging issues thrown up by developments in biotechnology. This volume is a comprehensive review of the protocol and the process that led to its adoption. It includes contributions from many of the key players involved and analyses the commercial and political interests at stake, the operations and implications of the protocol, and prospects for the future.
TABLE OF CONTENTS
part I|92 pages
Background: the road to the Cartagena Protocol and beyond
part II|186 pages
The making of the protocol: actors’ perspectives on the negotiations
part |10 pages
Miami Group
part |51 pages
Like-Minded Group
part |20 pages
European Union
part |26 pages
Compromise Group
part |6 pages
Central and Eastern Europe
part |33 pages
Environment ministers: political perspective on the final negotiations
part |22 pages
Environmental NGOs
part |6 pages
Industry
part III|176 pages
Key elements of the protocol
part IV|66 pages
Implications for environment, trade and development: an assessment